Literature DB >> 8891160

In vitro activities of five fluoroquinolone compounds against strains of Streptococcus pneumoniae with resistance to other antimicrobial agents.

A L Barry1, P C Fuchs, S D Brown.   

Abstract

Ciprofloxacin, clinafloxacin, PD 131628, sparfloxacin, and trovafloxacin were tested against 236 strains of Streptococcus pneumoniae, most of which were resistant to other agents. Resistance to multiple antibiotics did not affect the organism's susceptibility to the fluoroquinolones. The fluoroquinolones with in vitro antipneumococcal activity might be particularly useful against strains that are resistant to the more traditional therapeutic agents.

Entities:  

Mesh：

Substances：

Year:  1996        PMID： 8891160      PMCID： PMC163550     

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN： 0066-4804            Impact factor:   5.191


  11 in total

1.  Decreased susceptibility of penicillin-resistant pneumococci to twenty-four beta-lactam antibiotics.

Authors:  J Liñares; T Alonso; J L Pérez; J Ayats; M A Domínguez; R Pallarés; R Martín
Journal:  J Antimicrob Chemother       Date:  1992-09       Impact factor: 5.790

2.  Therapeutic failure and selection of resistance to quinolones in a case of pneumococcal pneumonia treated with ciprofloxacin.

Authors:  E Pérez-Trallero; J M Garcia-Arenzana; J A Jimenez; A Peris
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1990-12       Impact factor: 3.267

3.  Infectious complications with respiratory pathogens despite ciprofloxacin therapy.

Authors:  B L Lee; A M Padula; R C Kimbrough; S R Jones; R E Chaisson; J Mills; M A Sande
Journal:  N Engl J Med       Date:  1991-08-15       Impact factor: 91.245

4.  Pneumococcal bacteremia during ciprofloxacin therapy for pneumococcal pneumonia.

Authors:  B Cooper; M Lawlor
Journal:  Am J Med       Date:  1989-10       Impact factor: 4.965

5.  Antimicrobial resistance of Streptococcus pneumoniae recovered from outpatients in the United States during the winter months of 1994 to 1995: results of a 30-center national surveillance study.

Authors:  G V Doern; A Brueggemann; H P Holley; A M Rauch
Journal:  Antimicrob Agents Chemother       Date:  1996-05       Impact factor: 5.191

6.  High rates of erythromycin-resistant Streptococcus pneumoniae among penicillin-resistant strains.

Authors:  F Soriano; R Fernández-Roblas
Journal:  J Antimicrob Chemother       Date:  1993-03       Impact factor: 5.790

Review 7.  Pneumococcal resistance to beta-lactam antibiotics: a global geographic overview.

Authors:  F Baquero
Journal:  Microb Drug Resist       Date:  1995       Impact factor: 3.431

8.  In vitro activity of antibiotics commonly used in the treatment of otitis media against Streptococcus pneumoniae isolates with different susceptibilities to penicillin.

Authors:  M M Tarpay; D F Welch; H Salari; M I Marks
Journal:  Antimicrob Agents Chemother       Date:  1982-07       Impact factor: 5.191

9.  In-vitro activity of ten antimicrobial agents against penicillin-resistant Streptococcus pneumoniae.

Authors:  T J Neal; M A O'Donoghue; E J Ridgway; K D Allen
Journal:  J Antimicrob Chemother       Date:  1992-07       Impact factor: 5.790

Review 10.  Role of quinolones in the treatment of bronchopulmonary infections, particularly pneumococcal and community-acquired pneumonia.

Authors:  J P Thys; F Jacobs; B Byl
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1991-04       Impact factor: 3.267
View more
  8 in total

1.  Activities of newer fluoroquinolones against ciprofloxacin-resistant Streptococcus pneumoniae.

Authors:  E A Coyle; G W Kaatz; M J Rybak
Journal:  Antimicrob Agents Chemother       Date:  2001-06       Impact factor: 5.191

2.  Active efflux as a mechanism of resistance to ciprofloxacin in Streptococcus pneumoniae.

Authors:  V Zeller; C Janoir; M D Kitzis; L Gutmann; N J Moreau
Journal:  Antimicrob Agents Chemother       Date:  1997-09       Impact factor: 5.191

3.  The new fluoroquinolones: A critical review.

Authors:  G G Zhanel; A Walkty; L Vercaigne; J A Karlowsky; J Embil; A S Gin; D J Hoban
Journal:  Can J Infect Dis       Date:  1999-05

4.  In vitro activity of BAY 12-8039, a novel 8-methoxyquinolone, compared to activities of six fluoroquinolones against Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis.

Authors:  A B Brueggemann; K C Kugler; G V Doern
Journal:  Antimicrob Agents Chemother       Date:  1997-07       Impact factor: 5.191

5.  Chondrotoxicity and toxicokinetics of sparfloxacin in juvenile rats.

Authors:  R Stahlmann; U Zippel; C Förster; R Schwabe; M Shakibaei; H J Merker; K Borner
Journal:  Antimicrob Agents Chemother       Date:  1998-06       Impact factor: 5.191

6.  Prevalence of a putative efflux mechanism among fluoroquinolone-resistant clinical isolates of Streptococcus pneumoniae.

Authors:  N P Brenwald; M J Gill; R Wise
Journal:  Antimicrob Agents Chemother       Date:  1998-08       Impact factor: 5.191

Review 7.  Management of infections due to antibiotic-resistant Streptococcus pneumoniae.

Authors:  S L Kaplan; E O Mason
Journal:  Clin Microbiol Rev       Date:  1998-10       Impact factor: 26.132

8.  Carriage rate and serotypes of Streptococcus pneumoniae amongst children in Thika Hospital, Kenya.

Authors:  Susan Githii; Gunturu Revathi; Anne Muigai; Samuel Kariuki
Journal:  Afr J Lab Med       Date:  2013-05-20
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.